Episode 9 episode artwork

EPISODE · Apr 27, 2017 · 17 MIN

Episode 9

from ACCP · host ACCPpostgrads

SGLT2 Inhibitors: Drs. Nuffer and Trujillo discuss the nonglycemic outcomes, clinical implications, and adverse effects associated with SGLT2 inhibitor therapy in patients with type 2 diabetes.

SGLT2 Inhibitors: Drs. Nuffer and Trujillo discuss the nonglycemic outcomes, clinical implications, and adverse effects associated with SGLT2 inhibitor therapy in patients with type 2 diabetes.

NOW PLAYING

Episode 9

0:00 17:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of ACCP?

This episode is 17 minutes long.

When was this ACCP episode published?

This episode was published on April 27, 2017.

What is this episode about?

SGLT2 Inhibitors: Drs. Nuffer and Trujillo discuss the nonglycemic outcomes, clinical implications, and adverse effects associated with SGLT2 inhibitor therapy in patients with type 2 diabetes.

Can I download this ACCP episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!